Table 1 Summary of characteristics of included studies
Characteristic | Number of studies (%) |
|---|---|
Region | |
East Asia & Pacific | 12 (9) |
Europe & Central Asia | 29 (23) |
Latin America & Caribbean | 2 (2) |
Middle East & North Africa | 3 (2) |
North America | 54 (43) |
South Asia | 6 (5) |
Sub-Saharan Africa | 32 (25) |
Unspecified | 3 (2) |
Condition | |
Fetal abnormality | 10 (8) |
Fetal condition | 1 (1) |
Fetal Immunological condition | 8 (6) |
Infection | 62 (49) |
Labour complication | 14 (11) |
Maternal behaviour | 3 (2) |
Maternal condition | 11 (9) |
Maternal mental health | 1 (1) |
Maternal nutrition | 3 (2) |
Placental abnormality | 2 (2) |
Pre-existing maternal condition | 2 (2) |
Preterm birth | 7 (6) |
Various | 5 (4) |
Intervention type | |
Antenatal care | 1 (1) |
Behavioural | 3 (2) |
Clinical decision rule | 1 (1) |
Delivery method | 9 (7) |
Delivery timing | 1 (1) |
Exercise program | 1 (1) |
Fetal monitoring | 1 (1) |
Mobile Health (mHealth) | 1 (1) |
Pharmaceutical | 29 (23) |
Policy | 5 (4) |
Screening | 54 (43) |
Supplementation | 5 (4) |
Surgery | 2 (2) |
Surrogacy | 1 (1) |
Training | 2 (2) |
Vaccination | 11 (9) |
Various | 3 (2) |
Analysis type | |
Model | 99 (78) |
Trial | 13 (10) |
Both | 11 (9) |
Other | 4 (3) |
Time horizon | |
Delivery | 1 (0.8) |
48 h post-delivery | 1 (0.8) |
3 months | 2 (1.6) |
1 year | 2 (1.6) |
2 years | 1 (0.8) |
10 years | 1 (0.8) |
18 years | 1 (0.8) |
20 years | 3 (2) |
Maternal lifetime | 8 (6) |
Fetal lifetime | 97 (76) |
Not reported | 10 (8) |